Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Erich

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Genetic Analysis : Biomolecular Engineering|April 7, 1999
Nucleus extraction from single mounted tissue sectionsT Liehr, C Uwe, G Erich
Journal of the American Chemical Society|April 3, 2003
Theoretical elucidation of kinetic and thermodynamic control of radical addition regioselectivityAndrew G Leach, Renxiao Wang, G Erich Wohlhieter, et al.
Clinical Therapeutics|June 29, 2019
A Study on the Application and Use of Artificial Intelligence to Support Drug DevelopmentMary Jo Lamberti, Michael Wilkinson, Bruce A Donzanti, et al.
ACS Applied Nano Materials|October 2, 2025
Engineering the Colloidal Properties of Iron Oxide Nanoparticles for High <i>T</i> <sub>1</sub> MRI Contrast at 64 mTSamuel D Oberdick, Gabriella G Erich, Arabella R Stockdale, et al.
Chemical Research in Toxicology|January 26, 2010
Cytochrome P450-mediated epoxidation of 2-aminothiazole-based AKT inhibitors: identification of novel GSH adducts and reduction of metabolic activation through structural changes guided by in silico and in vitro screeningRaju Subramanian, Matthew R Lee, John G Allen, et al.
Bioorganic & Medicinal Chemistry Letters|February 9, 2010
2-Aminothiadiazole inhibitors of AKT1 as potential cancer therapeuticsQingping Zeng, Matthew P Bourbeau, G Erich Wohlhieter, et al.
Journal of Medicinal Chemistry|October 28, 2009
Discovery and optimization of chromenotriazolopyrimidines as potent inhibitors of the mouse double minute 2-tumor protein 53 protein-protein interactionJohn G Allen, Matthew P Bourbeau, G Erich Wohlhieter, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Genetic Analysis : Biomolecular Engineering|April 7, 1999
Nucleus extraction from single mounted tissue sectionsT Liehr, C Uwe, G Erich
Journal of the American Chemical Society|April 3, 2003
Theoretical elucidation of kinetic and thermodynamic control of radical addition regioselectivityAndrew G Leach, Renxiao Wang, G Erich Wohlhieter, et al.
Clinical Therapeutics|June 29, 2019
A Study on the Application and Use of Artificial Intelligence to Support Drug DevelopmentMary Jo Lamberti, Michael Wilkinson, Bruce A Donzanti, et al.
ACS Applied Nano Materials|October 2, 2025
Engineering the Colloidal Properties of Iron Oxide Nanoparticles for High <i>T</i> <sub>1</sub> MRI Contrast at 64 mTSamuel D Oberdick, Gabriella G Erich, Arabella R Stockdale, et al.
Chemical Research in Toxicology|January 26, 2010
Cytochrome P450-mediated epoxidation of 2-aminothiazole-based AKT inhibitors: identification of novel GSH adducts and reduction of metabolic activation through structural changes guided by in silico and in vitro screeningRaju Subramanian, Matthew R Lee, John G Allen, et al.
Bioorganic & Medicinal Chemistry Letters|February 9, 2010
2-Aminothiadiazole inhibitors of AKT1 as potential cancer therapeuticsQingping Zeng, Matthew P Bourbeau, G Erich Wohlhieter, et al.
Journal of Medicinal Chemistry|October 28, 2009
Discovery and optimization of chromenotriazolopyrimidines as potent inhibitors of the mouse double minute 2-tumor protein 53 protein-protein interactionJohn G Allen, Matthew P Bourbeau, G Erich Wohlhieter, et al.
Pageof 1